Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan.
Liang H, Nian X, Wu J, Liu D, Feng L, Lu J, Peng Y, Zhou Z, Deng T, Liu J, Ji D, Qiu R, Lin L, Zeng Y, Xia F, Hu Y, Li T, Duan K, Li X, Wang Z, Zhang Y, Zhang H, Zhu C, Wang S, Wu X, Wang X, Li Y, Huang S, Mao M, Guo H, Yang Y, Jia R, Xufang J, Wang X, Liang S, Qiu Z, Zhang J, Ding Y, Li C, Zhang J, Fu D, He Y, Zhou D, Li C, Zhang J, Yu D, Yang XM. Liang H, et al. Among authors: duan k. Cell Discov. 2022 Dec 9;8(1):131. doi: 10.1038/s41421-022-00496-x. Cell Discov. 2022. PMID: 36494338 Free PMC article.
Suspended cell lines for inactivated virus vaccine production.
Zhang J, Qiu Z, Wang S, Liu Z, Qiao Z, Wang J, Duan K, Nian X, Ma Z, Yang X. Zhang J, et al. Among authors: duan k. Expert Rev Vaccines. 2023 Jan-Dec;22(1):468-480. doi: 10.1080/14760584.2023.2214219. Expert Rev Vaccines. 2023. PMID: 37199282 Free article. Review.
Coping Strategies for Pertussis Resurgence.
Nian X, Liu H, Cai M, Duan K, Yang X. Nian X, et al. Among authors: duan k. Vaccines (Basel). 2023 Apr 24;11(5):889. doi: 10.3390/vaccines11050889. Vaccines (Basel). 2023. PMID: 37242993 Free PMC article. Review.
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.
Huang X, Liang J, Huang L, Nian X, Chen W, Zhang J, Xu X, Lin X, Wang Y, Shi J, Jia L, Li Q, Wang Q, Duan K, Li X, Ji Y, Peng F, Zhang W, Xie Z, Wang Y, Yang X. Huang X, et al. Among authors: duan k. Hum Vaccin Immunother. 2023 Dec 31;19(1):2211896. doi: 10.1080/21645515.2023.2211896. Epub 2023 May 30. Hum Vaccin Immunother. 2023. PMID: 37249318 Free PMC article. Clinical Trial.
Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection: A preclinical study.
Zhang J, Nian X, Liu B, Zhang Z, Zhao W, Han X, Ma Y, Jin D, Ma H, Zhang Q, Qiu R, Li F, Gong Z, Li X, Yang Y, Tian Y, Zhou L, Duan K, Li X, Ma Z, Yang X. Zhang J, et al. Among authors: duan k. Antiviral Res. 2023 Aug;216:105639. doi: 10.1016/j.antiviral.2023.105639. Epub 2023 Jun 1. Antiviral Res. 2023. PMID: 37270159 Free article.
CDC20 is a potential target gene to inhibit the tumorigenesis of MDCK cells.
Liu Z, Pei M, Liu G, Qiu Z, Wang S, Qiao Z, Wang J, Jin D, Zhang J, Duan K, Nian X, Ma Z, Yang X. Liu Z, et al. Among authors: duan k. Biologicals. 2023 Aug;83:101697. doi: 10.1016/j.biologicals.2023.101697. Epub 2023 Aug 14. Biologicals. 2023. PMID: 37579524 Free article.
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.
Liu Y, Zhang J, Liu W, Pan Y, Ruan S, Nian X, Chen W, Sun L, Yin Q, Yue X, Li Q, Gui F, Wu C, Wang S, Yang Y, Jing Z, Long F, Wang Z, Zhang Z, Huang C, Duan K, Liang M, Yang X. Liu Y, et al. Among authors: duan k. Emerg Microbes Infect. 2024 Dec;13(1):2284297. doi: 10.1080/22221751.2023.2284297. Epub 2024 Mar 26. Emerg Microbes Infect. 2024. PMID: 37970736 Free PMC article. Clinical Trial.
780 results